Meet the Speakers

Krishna Doniparthi, M.D.

Medical Director

Dr. Krishna Doniparth is one of the growing numbers of physicians leading a paradigm shift in health. He is a senior physician board-certified in regenerative & functional medicine, family medicine, and obesity medicine, holding degrees from Loyola University and Grace University Medical School. In addition, he completed his medical residency as Chief Medical Resident at Alabama University.

Dr. Doniparthi practices functional medicine in Alpharetta, GA, focusing on biological substrates for cellular detoxification to help children and adults with complex medical conditions due to epigenetic changes in the individual. Functional Medicine Georgia (www.FMG.health) is the name of his practice where he is a partner in health to all his patients and, in that role, is dedicated to working with them to learn, develop and treat their individual needs for restorative health. The cornerstone of the work he and his patients undergo involves biological substrates that provide the foundation for biochemical reactions, vitamins which are organic compounds necessary for normal physiological functioning, and minerals, which are inorganic substances that play essential roles in maintaining bodily functions. He firmly believes in working with the body to heal itself with the proper inputs and that food is thy medicine for sustained health.

Outside the clinic, Dr. Doniparthi is a leader, speaker, educator, and advocate in the field of fatty acids and phospholipids to develop and maintain strong, healthy cells in the body to combat illness. He is the Founder and Director of Doniparthi Neurogen Academy nonprofit (www.dnadr.org), where he provides education and training to fellow healthcare providers in implementing his clinical treatments for long COVID, vaccine injury, mold/fungus infections, neurological disorders, and other intricate medical conditions.

Dr. Doniparthi’s research focuses primarily on fatty acids and phospholipids in pre-conception medicine and their potential effect on spectrum disorders, cancer, and genetic/epigenetic predispositions. In addition, he is a Senior Advisor for the Scientific Advisory Board for NAD+ Research, an enthusiastic MAPS Adjunct Faculty member, and a former Trustee of the Obesity Medicine Association.

For the past three years, Dr. Doniparthi has worked in the trenches to manage the COVID infection, Post-COVID sequelae, and vaccine injury utilizing biological substrates, targeted supplements, and one now popular RX. He has been faithful to the foundational principles of science in his clinical practice and research through collaboration with informed and unencumbered healthcare providers in private group discussions, conferences, and reviews of global reports. Dr. Doniparthi is an enthusiastic leader in the new health paradigm.